Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

Association between potassium level and outcomes in heart failure with reduced ejection fraction: a cohort study from the Swedish Heart Failure Registry

(2020) Lauren B. Cooper et al.   EUROPEAN JOURNAL OF HEART FAILURE

Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction

(2019) Hans-Peter Brunner-La Rocca et al.   JACC-Heart Failure

Heart failure drug treatment

(2019) Patrick Rossignol et al.   LANCET

A new area for the management of hyperkalaemia with potassium binders: clinical use in nephrology

(2019) Patrick Rossignol   EUROPEAN HEART JOURNAL SUPPLEMENTS

Serum Potassium and Cardiovascular Events in Heart Failure With Preserved Left Ventricular Ejection Fraction Patients

(2018) Taiki Nishihara et al.   AMERICAN JOURNAL OF HYPERTENSION

Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists

(2018) Marco Trevisan et al.   EUROPEAN JOURNAL OF HEART FAILURE

Is hyperkalaemia in heart failure a risk factor or a risk marker? Implications for renin-angiotensin-aldosterone system inhibitor use

(2018) Lars H. Lund et al.   EUROPEAN JOURNAL OF HEART FAILURE

Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF

(2018) Joost C. Beusekamp et al.   EUROPEAN JOURNAL OF HEART FAILURE

Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry

(2018) Gianluigi Savarese et al.   EUROPEAN JOURNAL OF HEART FAILURE

Medical Therapy for Heart Failure With Reduced Ejection Fraction

(2018) Stephen J. Greene et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

OUP accepted manuscript

(2018)   EUROPEAN HEART JOURNAL

Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction

(2018) Gianluigi Savarese et al.   JACC-Heart Failure

Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study

(2017) W. Ouwerkerk et al.   EUROPEAN HEART JOURNAL

Association between enrolment in a heart failure quality registry and subsequent mortality-a nationwide cohort study

(2017) Lars H. Lund et al.   EUROPEAN JOURNAL OF HEART FAILURE

Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry

(2017) Michel Komajda et al.   EUROPEAN JOURNAL OF HEART FAILURE

Hyperkalemia After Initiating Renin–Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project

(2017) Ghassan Bandak et al.   Journal of the American Heart Association

Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril

(2017) Akshay S. Desai et al.   JAMA Cardiology

Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality

(2017) Julio Núñez et al.   CIRCULATION

Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012

(2016) Tonje Thorvaldsen et al.   EUROPEAN JOURNAL OF HEART FAILURE

European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions

(2016) Maria G. Crespo-Leiro et al.   EUROPEAN JOURNAL OF HEART FAILURE

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Antihypertensive Medications and the Prevalence of Hyperkalemia in a Large Health SystemNovelty and Significance

(2016) Alex R. Chang et al.   HYPERTENSION

Underprescription of Renin–Angiotensin System Blockers in Moderate to Severe Chronic Kidney Disease

(2015) Shayan Shirazian et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Association between renin–angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study

(2015) Magnus Edner et al.   EUROPEAN HEART JOURNAL

Incidence, Predictors, and Outcomes Related to Hypo- and Hyperkalemia in Patients With Severe Heart Failure Treated With a Mineralocorticoid Receptor Antagonist

(2014) Orly Vardeny et al.   Circulation-Heart Failure

Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care

(2013) Anne Gjesing et al.   EUROPEAN JOURNAL OF HEART FAILURE

Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

(2013) Aldo P. Maggioni et al.   EUROPEAN JOURNAL OF HEART FAILURE

EURObservationalResearch Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)

(2013) Aldo P. Maggioni et al.   EUROPEAN JOURNAL OF HEART FAILURE

A Simple Unified Approach for Estimating Natural Direct and Indirect Effects

(2012) Theis Lange et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial

(2011) B. Pitt et al.   EUROPEAN HEART JOURNAL